Annual Total Liabilities
$169.09 M
+$34.10 M+25.26%
31 December 2023
Summary:
TG Therapeutics annual total liabilities is currently $169.09 million, with the most recent change of +$34.10 million (+25.26%) on 31 December 2023. During the last 3 years, it has risen by +$62.79 million (+59.08%). TGTX annual total liabilities is now at all-time high.TGTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$393.86 M
+$170.22 M+76.11%
30 September 2024
Summary:
TG Therapeutics quarterly total liabilities is currently $393.86 million, with the most recent change of +$170.22 million (+76.11%) on 30 September 2024. Over the past year, it has increased by +$227.56 million (+136.84%). TGTX quarterly total liabilities is now at all-time high.TGTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.3% | +136.8% |
| 3 y3 years | +59.1% | +301.2% |
| 5 y5 years | +183.8% | +230.6% |
TGTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +59.1% | at high | +301.2% |
| 5 y | 5 years | at high | +183.8% | at high | +301.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TG Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $393.86 M(+76.1%) |
| June 2024 | - | $223.64 M(+4.9%) |
| Mar 2024 | - | $213.21 M(+26.1%) |
| Dec 2023 | $169.09 M(+25.3%) | $169.09 M(+1.7%) |
| Sept 2023 | - | $166.30 M(-7.8%) |
| June 2023 | - | $180.40 M(+6.2%) |
| Mar 2023 | - | $169.93 M(+25.9%) |
| Dec 2022 | $134.99 M(-5.3%) | $134.99 M(+15.0%) |
| Sept 2022 | - | $117.41 M(-4.3%) |
| June 2022 | - | $122.63 M(-7.5%) |
| Mar 2022 | - | $132.64 M(-6.9%) |
| Dec 2021 | $142.48 M(+34.0%) | $142.48 M(+45.1%) |
| Sept 2021 | - | $98.17 M(-0.1%) |
| June 2021 | - | $98.27 M(-5.0%) |
| Mar 2021 | - | $103.41 M(-2.7%) |
| Dec 2020 | $106.29 M(-14.6%) | $106.29 M(+3.0%) |
| Sept 2020 | - | $103.20 M(+2.8%) |
| June 2020 | - | $100.39 M(-2.7%) |
| Mar 2020 | - | $103.20 M(-17.0%) |
| Dec 2019 | $124.40 M(+108.8%) | $124.40 M(+4.4%) |
| Sept 2019 | - | $119.12 M(+27.6%) |
| June 2019 | - | $93.38 M(-5.0%) |
| Mar 2019 | - | $98.28 M(+65.0%) |
| Dec 2018 | $59.58 M(+96.1%) | $59.58 M(+39.8%) |
| Sept 2018 | - | $42.63 M(+8.4%) |
| June 2018 | - | $39.34 M(+10.0%) |
| Mar 2018 | - | $35.76 M(+17.7%) |
| Dec 2017 | $30.39 M(+60.7%) | $30.39 M(+36.7%) |
| Sept 2017 | - | $22.24 M(-4.3%) |
| June 2017 | - | $23.22 M(+4.5%) |
| Mar 2017 | - | $22.21 M(+17.5%) |
| Dec 2016 | $18.91 M(+58.9%) | $18.91 M(-0.1%) |
| Sept 2016 | - | $18.93 M(+17.6%) |
| June 2016 | - | $16.10 M(+51.6%) |
| Mar 2016 | - | $10.62 M(-10.8%) |
| Dec 2015 | $11.90 M(+79.1%) | $11.90 M(+7.3%) |
| Sept 2015 | - | $11.10 M(+4.1%) |
| June 2015 | - | $10.66 M(-3.5%) |
| Mar 2015 | - | $11.04 M(+66.1%) |
| Dec 2014 | $6.64 M(-17.5%) | $6.64 M(-36.5%) |
| Sept 2014 | - | $10.46 M(+148.8%) |
| June 2014 | - | $4.21 M(+12.4%) |
| Mar 2014 | - | $3.74 M(-53.6%) |
| Dec 2013 | $8.06 M(+23.5%) | $8.06 M(-16.6%) |
| Sept 2013 | - | $9.66 M(+27.4%) |
| June 2013 | - | $7.58 M(+13.4%) |
| Mar 2013 | - | $6.69 M(+2.5%) |
| Dec 2012 | $6.52 M(+33.1%) | $6.52 M(-11.1%) |
| Sept 2012 | - | $7.34 M(+8.8%) |
| June 2012 | - | $6.74 M(+14.6%) |
| Mar 2012 | - | $5.89 M(+20.1%) |
| Dec 2011 | $4.90 M(-79.6%) | $4.90 M(-73.3%) |
| Sept 2011 | - | $18.36 M(-10.5%) |
| June 2011 | - | $20.51 M(+2.8%) |
| Mar 2011 | - | $19.96 M(-16.8%) |
| Dec 2010 | $24.00 M | $24.00 M(-3.1%) |
| Sept 2010 | - | $24.77 M(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $25.38 M(-8.1%) |
| Mar 2010 | - | $27.60 M(+286.0%) |
| Dec 2009 | $7.15 M(+27.1%) | $7.15 M(-2.4%) |
| Sept 2009 | - | $7.33 M(-1.6%) |
| June 2009 | - | $7.45 M(+13.4%) |
| Mar 2009 | - | $6.56 M(+16.7%) |
| Dec 2008 | $5.62 M(+200.5%) | $5.62 M(+13.3%) |
| Sept 2008 | - | $4.96 M(+12.3%) |
| June 2008 | - | $4.42 M(+147.4%) |
| Mar 2008 | - | $1.79 M(-4.6%) |
| Dec 2007 | $1.87 M(-3.7%) | $1.87 M(+4.5%) |
| Sept 2007 | - | $1.79 M(-29.2%) |
| June 2007 | - | $2.53 M(+15.4%) |
| Mar 2007 | - | $2.19 M(+12.8%) |
| Dec 2006 | $1.94 M(+16.7%) | $1.94 M(+37.4%) |
| Sept 2006 | - | $1.41 M(-36.1%) |
| June 2006 | - | $2.21 M(-1.4%) |
| Mar 2006 | - | $2.25 M(+34.9%) |
| Dec 2005 | $1.67 M(+39.3%) | $1.67 M(-7.9%) |
| Sept 2005 | - | $1.81 M(+1.9%) |
| June 2005 | - | $1.78 M(+39.7%) |
| Mar 2005 | - | $1.27 M(+6.3%) |
| Dec 2004 | $1.20 M(+23.8%) | $1.20 M(-18.9%) |
| Sept 2004 | - | $1.47 M(+136.2%) |
| June 2004 | - | $624.40 K(-17.6%) |
| Mar 2004 | - | $757.80 K(-21.6%) |
| Dec 2003 | $966.00 K(-10.8%) | $966.00 K(-23.7%) |
| Sept 2003 | - | $1.27 M(+20.0%) |
| June 2003 | - | $1.05 M(-0.8%) |
| Mar 2003 | - | $1.06 M(-1.8%) |
| Dec 2002 | $1.08 M(+113.0%) | $1.08 M(+115.0%) |
| Sept 2002 | - | $503.90 K(+17.8%) |
| June 2002 | - | $427.70 K(-11.8%) |
| Mar 2002 | - | $484.70 K(-4.7%) |
| Dec 2001 | $508.60 K(-75.6%) | $508.60 K(-32.0%) |
| Sept 2001 | - | $748.40 K(+5.9%) |
| June 2001 | - | $706.90 K(-9.3%) |
| Mar 2001 | - | $779.20 K(-62.5%) |
| Dec 2000 | $2.08 M(+246.7%) | $2.08 M(+95.9%) |
| Sept 2000 | - | $1.06 M(+95.7%) |
| June 2000 | - | $542.50 K(+9.4%) |
| Mar 2000 | - | $495.90 K(-17.3%) |
| Dec 1999 | $600.00 K(0.0%) | $600.00 K(+200.0%) |
| Sept 1999 | - | $200.00 K(-50.0%) |
| June 1999 | - | $400.00 K(+33.3%) |
| Mar 1999 | - | $300.00 K(-50.0%) |
| Dec 1998 | $600.00 K(+50.0%) | $600.00 K(0.0%) |
| Sept 1998 | - | $600.00 K(0.0%) |
| June 1998 | - | $600.00 K(+200.0%) |
| Mar 1998 | - | $200.00 K(-50.0%) |
| Dec 1997 | $400.00 K(+33.3%) | $400.00 K(+33.3%) |
| Sept 1997 | - | $300.00 K(0.0%) |
| June 1997 | - | $300.00 K(0.0%) |
| Mar 1997 | - | $300.00 K(0.0%) |
| Dec 1996 | $300.00 K | $300.00 K(-25.0%) |
| Sept 1996 | - | $400.00 K(0.0%) |
| June 1996 | - | $400.00 K |
FAQ
- What is TG Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for TG Therapeutics?
- What is TG Therapeutics annual total liabilities year-on-year change?
- What is TG Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly total liabilities year-on-year change?
What is TG Therapeutics annual total liabilities?
The current annual total liabilities of TGTX is $169.09 M
What is the all time high annual total liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total liabilities is $169.09 M
What is TG Therapeutics annual total liabilities year-on-year change?
Over the past year, TGTX annual total liabilities has changed by +$34.10 M (+25.26%)
What is TG Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TGTX is $393.86 M
What is the all time high quarterly total liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total liabilities is $393.86 M
What is TG Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TGTX quarterly total liabilities has changed by +$227.56 M (+136.84%)